A new drug is being trialled at two hospitals in Manchester as part of a nationwide effort to find new treatments for COVID-19.
The Manchester Royal Infirmary (MRI) and Wythenshawe Hospital are taking part in a national research programme exploring different drugs for people hospitalised by coronavirus.
Bemcentinib, a tablet used to treat blood disorders, is one of the drugs being tested on Covid patients at the MRI and Wythenshawe Hospital, part of Manchester University NHS Foundation Trust (MFT).
The study falls under the ACCORD-2 (accelerating Covid-19 research and development), one of several research studies trials taking place at MFT as part of COVID-19 urgent public health research.
As an adaptive study, drugs and therapies can be added or removed as researchers progress.
Bemcentinib, a drug developed by the Norwegian company BerGenBio, has been shown to have a potent anti-viral effect in other experiments, according to scientists.
It is is one of five drugs being tested at 30 hospitals in the UK as part of a national research effort involving doctors and scientists, the National Institute for Health Research (NIHR) and UK Research and Innovation.
Scientists hope their wider findings could reduce the severity of the disease, shorten the length of someone's illness and prevent patients from being admitted to intensive care units (ICU).
As with all most trials, researchers rely on patients and their families signing up to become part of their crucial work.
Greater Manchester's hospitals are already playing crucial roles in COVID-19 research.
Twelve urgent public health trials are underway in our region alone.
While developing a vaccine is viewed as 'the gold standard', research into testing, diagnosis and treatment will be key in adapting to life with coronavirus in the long-term.
More than 5,000 coronavirus patients have already taken part in clinical trials in Greater Manchester.
Anyone wanting to know more about research into COVID-19, and how to potentially get involved, can visit the NIHR’s Be Part of Research website here.
To keep up with the latest breaking news and information on Covid-19 and the lockdown, and for things to do while you are staying in, join our dedicated coronavirus Facebook group.
